Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
31.94
-0.55 (-1.69%)
At close: Aug 24, 2026
SHA:603014 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SHA:603014 stock has a consensus rating of "Strong Buy" and an average price target of ¥44.25. The average 1-year stock price forecast is 38.54% higher than the current stock price, while the lowest is ¥42.00 (+31.50%) and the highest is ¥46.50 (+45.59%).
Price Target: ¥44.25 (+38.54%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SHA:603014 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 3 | 3 |
Financial Forecast
Revenue This Year
4.07B
from 3.77B
Increased by 7.86%
Revenue Next Year
4.45B
from 4.07B
Increased by 9.52%
EPS This Year
1.17
from 1.17
EPS Next Year
1.32
from 1.17
Increased by 12.82%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.